Oncology patient-reported claims: Maximising the chance for success

ecancermedicalscience

Volumn 5, Issue 1, 2011, Pages

  Kitchen, H ^a   Rofail, D ^a   Caron, M ^b   Emery, M P ^b  

^a MAPI VALUES   (United States)

^b MAPI Research Trust   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; DATA BASE; EUROPE; FOOD AND DRUG ADMINISTRATION; HUMAN; PATIENT REPORTED OUTCOME; QUESTIONNAIRE; REVIEW; UNITED STATES; WEB BROWSER;

EID: 84857027761     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2011.212     Document Type: Review

References (13)

1. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and REsearch (CBER), Center for Devices and Radiological Health (CDRH) (2009) Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
2. Marquis P, Arnould B, Acquadro C (2006) Patient-reported outcomes and health-related quality of life in effectiveness studies: pros and cons Drug Dev Res 67 193-201 doi:10.1002/ddr.20077 (Pubitemid 44099979)
3. Burke LB, Kennedy DL, Miskala PH, Papadopoulos EJ, Trentacosti AM (2008) The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval Clin Pharmacol Ther 84 281-3 PMID: 18580868
4. Victorson D, Soni M, Cella D (2006) Metaanalysis of the correlation between radiographic tumor response and patient reported outcomes Cancer 106 494-504 PMID: 16353212 (Pubitemid 43157611)
5. Gondek K, Sagnier PP, Gilchrist K, Woolley JM (2007) Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels J Clin Oncol 25 5087-93 PMID: 17991926 (Pubitemid 350232288)
6. Sonneveld DJ, Hoekstra HJ, van der Graaf WT, Sluiter WJ, Mulder NH, Willemse PH et al (2001) Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era Cancer 91 1304-15 PMID: 11283931 (Pubitemid 32267042)
7. Giordano SH, Buzdar AU, Smith TL, Kau S-W, Yang Y, Hortobagyi GN (2003) Is breast cancer survival improving? Cancer 100 44-52 PMID: 14692023
8. Committee for Medicinal Products for Human Use (CHMP) (2005) Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicine products EMEA/CHMP/EWP/139391/2004 http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500003637.pdf
9. Gotay CC, Kawamoto CT, Bottomley A, Efficace F (2008) The prognostic significance of patient-reported outcomes in cancer clinical trials J Clin Oncol 26 1355-63 PMID: 18227528
10. Karvonen-Gutierrez CA, Ronis DL, Fowler KE, Terrell JE, Gruber SB, Duffy SA (2008) Quality of life scores predict survival among patients with head and neck cancer J Clin Oncol 26 2754-60 PMID: 18509185
11. Robinson DWJ, Eisenberg DF, Cella D, Zhao N, de Boer C, DeWitte M (2008) The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia J Support Oncol 6 283-90 PMID: 18724539
12. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH) (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance Health Qual Life Outcomes 4 79 PMID: 17034633
13. Sridhara R, Chen C, Chi GYH, Griebel DJ (2004) Evaluation of health-related quality-of-life measures in oncology drug product applications: issues and concerns J Biopharm Stat 14 23-5 PMID: 15027498